13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SCHEDULE Filed 2025-01-21 Event 2025-01-16 SEC 0001072613-25-000057 →

Growth Equity Opportunities Fund IV, LLC Verona Pharma plc

Stake: 4.99% Shares: 32,679,649 CUSIP: 925050106 Class: Ordinary Shares, nominal value 0.05 GBP

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
2 13D/G filings on this issuer
1 other filing besides this one
Filer Track Record
3 filings by this filer
2 other filings in the data moat
Short Interest
Not in latest FINRA snapshot

Other 13D/G Filings on Verona Pharma plc

FiledFormFilerStakeShares
2018-01-26 SC ORBIMED ADVISORS LLC view →

Other Filings by Growth Equity Opportunities Fund IV, LLC

FiledFormIssuerStakeShares
2018-03-19 SC Cascadian Therapeutics, Inc. view →
2018-03-05 SC ARCA biopharma, Inc. ORKA view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →